Cargando…

Glioblastoma specific antigens, GD2 and CD90, are not involved in cancer stemness

Glioblastoma multiforme (GBM) is the most malignant World Health Organization grade IV brain tumor. GBM patients have a poor prognosis because of its resistance to standard therapies, such as chemotherapy and radiation. Since stem-like cells have been associated with the treatment resistance of GBM,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Woo, Seon Rang, Oh, Young Taek, An, Jae Yeol, Kang, Bong Gu, Nam, Do-Hyun, Joo, Kyeung Min
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Association of Anatomists 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4371180/ https://www.ncbi.nlm.nih.gov/pubmed/25806121 http://dx.doi.org/10.5115/acb.2015.48.1.44

Ejemplares similares

KML001, a Telomere-Targeting Drug, Sensitizes Glioblastoma Cells to Temozolomide Chemotherapy and Radiotherapy through DNA Damage and Apoptosis
por: Woo, Seon Rang, et al.
Publicado: (2014)

Targeting GD2-positive glioblastoma by chimeric antigen receptor empowered mesenchymal progenitors
por: Golinelli, Giulia, et al.
Publicado: (2018)

Targeting the epithelial to mesenchymal transition in glioblastoma: the emerging role of MET signaling
por: Lee, Jin-Ku, et al.
Publicado: (2014)

NTRK1 Fusion in Glioblastoma Multiforme
por: Kim, Jinkuk, et al.
Publicado: (2014)

GD2 CAR T cells against human glioblastoma
por: Prapa, Malvina, et al.
Publicado: (2021)

Thermochemical investigations in the system Cd–Gd
por: Reichmann, Thomas L., et al.
Publicado: (2014)

Reinvestigation of the Cd–Gd phase diagram
por: Reichmann, Thomas L., et al.
Publicado: (2014)

Talin1 targeting potentiates anti-angiogenic therapy by attenuating invasion and stem-like features of glioblastoma multiforme
por: Kang, Wonyoung, et al.
Publicado: (2015)

Translational Validation of Personalized Treatment Strategy Based on Genetic Characteristics of Glioblastoma
por: Oh, Young Taek, et al.
Publicado: (2014)

High-Content Analysis-Based Sensitivity Prediction and Novel Therapeutics Screening for c-Met-Addicted Glioblastoma
por: Oh, Jeong-Woo, et al.
Publicado: (2021)

Natural killer (NK) cells inhibit systemic metastasis of glioblastoma cells and have therapeutic effects against glioblastomas in the brain
por: Lee, Se Jeong, et al.
Publicado: (2015)

Targeting and killing glioblastoma with monoclonal antibody to O-acetyl GD2 ganglioside
por: Fleurence, Julien, et al.
Publicado: (2016)

The Protein Neddylation Inhibitor MLN4924 Suppresses Patient-Derived Glioblastoma Cells via Inhibition of ERK and AKT Signaling
por: Han, Suji, et al.
Publicado: (2019)

Immunohistochemical study on the expression of calcium binding proteins (calbindin-D28k, calretinin, and parvalbumin) in the cerebral cortex and in the hippocampal region of nNOS knock-out(-/-) mice
por: Cho, Yu Jin, et al.
Publicado: (2011)

Disialogangliosides GD2 and GD3 are involved in the attachment of human melanoma and neuroblastoma cells to extracellular matrix proteins
Publicado: (1986)

Potent effect of the MDM2 inhibitor AMG232 on suppression of glioblastoma stem cells
por: Her, Nam-Gu, et al.
Publicado: (2018)

Safety and antitumor activity of GD2-Specific 4SCAR-T cells in patients with glioblastoma
por: Liu, Zhuohao, et al.
Publicado: (2023)

Human melanoma antigen AH is an autoantigenic ganglioside related to GD2
Publicado: (1982)

Idiopathic bone cavity: clinical and radiological features of 90 retrospective cases and surgical treatment
por: Ryu, Jihye, et al.
Publicado: (2021)

HSP90A inhibition promotes anti-tumor immunity by reversing multi-modal resistance and stem-like property of immune-refractory tumors
por: Song, Kwon-Ho, et al.
Publicado: (2020)

In vivo RNAi screen identifies NLK as a negative regulator of mesenchymal activity in glioblastoma
por: Sa, Jason K., et al.
Publicado: (2015)

CD44v6, STn & O-GD2: promising tumor associated antigens paving the way for new targeted cancer therapies
por: Lodewijk, Iris, et al.
Publicado: (2023)

Methionine consumption by cancer cells drives a progressive upregulation of PD-1 expression in CD4 T cells
por: Pandit, Mahesh, et al.
Publicado: (2023)

CD20 Positive T Cell Lymphoma Involvement of Skin
por: Lee, Ki Yeol, et al.
Publicado: (2011)

Self-patterning Gd nano-fibers in Mg-Gd alloys
por: Li, Yangxin, et al.
Publicado: (2016)

Targeting disialoganglioside GD2 with chimeric antigen receptor-redirected T cells in lung cancer
por: Reppel, Loïc, et al.
Publicado: (2022)

Identification of prognostic biomarkers for glioblastomas using protein expression profiling
por: JUNG, YONG, et al.
Publicado: (2011)

NANOG confers resistance to complement-dependent cytotoxicity in immune-edited tumor cells through up-regulating CD59
por: Son, Sung Wook, et al.
Publicado: (2022)

Targeting GD2-positive Refractory/Resistant Neuroblastoma and Osteosarcoma with Anti- CD3 x Anti-GD2 Bispecific Antibody Armed T cells
por: Yankelevich, Maxim, et al.
Publicado: (2023)

Digital TDPAC with rare earth isotope $^{169}$Yb, $^{147}$Gd, and $^{149}$Gd in Yb and Gd Doped CeO$_{2}$ and $^{147}$Gd in GdBa$_{2}$ Cu$_{3}$ O$_{7−\delta}$
por: Roeder, Jens, et al.
Publicado: (2011)

Tumor Progression Locus 2 (Tpl2) Kinase as a Novel Therapeutic Target for Cancer: Double-Sided Effects of Tpl2 on Cancer
por: Lee, Hye Won, et al.
Publicado: (2015)

Active Learning Performance in Labeling Radiology Images Is 90% Effective
por: Bangert, Patrick, et al.
Publicado: (2021)

FoxM1 Promotes Stemness and Radio-Resistance of Glioblastoma by Regulating the Master Stem Cell Regulator Sox2
por: Lee, Yeri, et al.
Publicado: (2015)

THY-1 Cell Surface Antigen (CD90) Has an Important Role in the Initial Stage of Human Cytomegalovirus Infection
por: Li, Qingxue, et al.
Publicado: (2015)

The effects of three different contrast agents (Gd-BOPTA, Gd-DTPA, and Gd-DOTA) on brachial plexus magnetic resonance imaging
por: Zhang, Xiaojing, et al.
Publicado: (2021)

Gardenia jasminoides extract and its constituent, genipin, inhibit activation of CD3/CD28 co-stimulated CD4(+) T cells via ORAI1 channel
por: Kim, Hyun Jong, et al.
Publicado: (2020)

GD2 and GD3 synthase: novel drug targets for cancer therapy
por: Sphyris, Nathalie, et al.
Publicado: (2015)

Cross-Activation of Regulatory T Cells by Self Antigens Limits Self-Reactive and Activated CD8(+) T Cell Responses
por: Cho, Eunjung, et al.
Publicado: (2023)

Quantitative Evaluation of Liver Function with MRI Using Gd-EOB-DTPA
por: Ryeom, Hun-Kyu, et al.
Publicado: (2004)

Functional Specialty of CD40 and Dendritic Cell Surface Lectins for Exogenous Antigen Presentation to CD8(+) and CD4(+) T Cells
por: Yin, Wenjie, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ap74oh3dfen02vdofnssq8vnt9